ALB · 8-K · 20260805PR000101
Operating Expense Trends
ALBEMARLE CORP · 2026-08-05 · Importance 56 · Surprise 46 · In source text
Second-quarter selling, general and administrative expense declined 4.6% year over year to $126.4 million from $132.5 million. Research and development expense declined 70.5% to $3.7 million from $12.4 million. Six-month SG&A increased 3.0% to $263.8 million, while six-month R&D declined 51.6% to $12.8 million from $26.5 million. The company also recorded $19.0 million of consulting expenses in SG&A during the quarter related to its strategic cost-savings initiative.
Key facts
- Corporate FY2026 depreciation and amortization expected $660 - $680 million source
- Delivered $100 million in year-to-date run-rate cost and productivity improvements source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | probable | -19.2% | Corporate FY2026 depreciation and amortization expected $660 - $680 million |
| operating_income | positive | realized | +5.7% | Delivered $100 million in year-to-date run-rate cost and productivity improvements |